Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia

Malignant Solid Neoplasm Clinical Trial

Official title:

Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia: A Pilot Feasibility Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05060328
• Other study ID #: 2020-1345
• Secondary ID: NCI-2021-0911620
• Status: Completed
• Start date: June 22, 2021
• Est. completion date: March 22, 2022

Study information

• Verified date: March 2022
• Source: M.D. Anderson Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. The Google Translate "Conversation Mode" translation application is designed to provide translation from one language to another and used to allow the nurse or study doctor to communicate with patients in Spanish by asking pre-prepared questions through an electronic device such as an iPad or iPhone. Google Translate "Conversation Mode" may facilitate assessment of pain and nausea after surgery in Spanish speaking patients.

Description:

PRIMARY OBJECTIVE:

I. To determine the feasibility of Google Translate "Conversation Mode" use to assess postoperative surgical pain presence, location and intensity, and nausea presence and intensity in Spanish speaking patients in the post-anesthesia care unit (PACU).

SECONDARY OBJECTIVES:

I. To evaluate the length of stay in PACU. II. To assess patient satisfaction with regards to pain/nausea experienced in PACU.

III. To determine nursing satisfaction with regards to the use of Google Translate "Conversation Mode".

OUTLINE:

Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: March 22, 2022
• Est. primary completion date: March 22, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Ability to provide written informed consent

• Patients between 18-80 years of age whose primary language is Spanish and will require translation services as part of standard care

• American Society of Anesthesiologists physical status (ASA) 1-3

• Are scheduled surgery under general anesthesia

• Ability to understand and complete all study questionnaires

Exclusion Criteria:

• Emergency surgery

• ASA >= 4

• Patients who do not require official translation services for consent purposes

• Patients who have chronic pain and/or are taking opioids chronically (daily intake for more than a month before surgery)

• Patients who undergo craniotomy

• Patients with a hearing impairment that prevents the ability to hear the recorded statements; and/or a cognitive impairment that would prevent them from completing post-op assessments

Related Conditions & MeSH terms

• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm
• Neoplasms

Intervention

Other:
• Medical Device Usage and Evaluation
Use Google Translate "Conversation Mode" translation application.
• Survey Administration
Complete survey

Locations

Country	Name	City	State
United States	M D Anderson Cancer Center	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ability to respond to the questions when asked using Google Translate	The feasibility rate and its 95% confidence interval will be estimated.	1 year

External Links

•   MD Anderson Cancer Center Website